PharmaGenoma

PharmaGenoma, Inc. was a molecular dermatology company that pioneered the development of genetic tests for skin and hair conditions. The company is best known for launching HairDX, the first genetic test to predict the risk of androgenetic alopecia (male and female pattern baldness), and PsoriasisDX, a genetic screening tool for psoriatic arthritis. Headquartered in Irvine, California, PharmaGenoma operated through specialized subsidiaries to commercialize its diagnostic products. The company's assets and product portfolio were eventually acquired by Daniel Alain, Inc., which integrated the genetic testing services into its hair loss solution offerings. Its leadership included experts in genomics and dermatology who focused on personalized medicine for aesthetic and inflammatory conditions.